OGN:NYE-Organon & Co (USD)

COMMON STOCK | Drug Manufacturers - General |

Last Closing

USD 18.55

Change

0.00 (0.00)%

Market Cap

USD 4.56B

Volume

2.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
LLY Eli Lilly and Company

N/A

USD 733.28B
JNJ Johnson & Johnson

N/A

USD 360.64B
MRK Merck & Company Inc

N/A

USD 318.60B
ABBV AbbVie Inc

N/A

USD 283.86B
NVS Novartis AG ADR

N/A

USD 202.14B
PFE Pfizer Inc

N/A

USD 157.25B
BMY Bristol-Myers Squibb Company

N/A

USD 91.10B
GSK GlaxoSmithKline PLC ADR

N/A

USD 90.02B

ETFs Containing OGN

DES WisdomTree U.S. SmallCap .. 1.55 % 0.38 %

N/A

USD 1.92B
EQUL IndexIQ ETF Trust - IQ En.. 1.48 % 0.00 %

N/A

USD 6.71M
SLYV SPDR® S&P 600 Small Cap .. 0.92 % 0.15 %

N/A

USD 3.86B
IJS iShares S&P Small-Cap 600.. 0.91 % 0.25 %

N/A

USD 6.91B
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

N/A

USD 0.01B
PSCH Invesco S&P SmallCap Heal.. 0.00 % 0.29 %

N/A

USD 0.20B
RNMC First Trust Mid Cap US Eq.. 0.00 % 0.60 %

N/A

USD 0.02B
PQLC 0.00 % 0.00 %

N/A

N/A
VIOV Vanguard S&P Small-Cap 60.. 0.00 % 0.20 %

N/A

USD 1.28B
XPH SPDR® S&P Pharmaceutical.. 0.00 % 0.35 %

N/A

USD 0.20B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 28.64% 100% F 96% N/A
Dividend Return 1.94% 67% D+ 78% C+
Total Return 30.58% 100% F 96% N/A
Trailing 12 Months  
Capital Gain -24.69% 33% F 10% F
Dividend Return 4.55% 100% F 65% D
Total Return -20.14% 33% F 11% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -17.06% 11% F 5% F
Dividend Return -14.91% 11% F 5% F
Total Return 2.15% 22% F 49% F
Risk Return Profile  
Volatility (Standard Deviation) 17.83% 44% F 61% D-
Risk Adjusted Return -83.61% 11% F 3% F
Market Capitalization 4.56B 11% F 75% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector